China SXT Pharmaceuticals, Inc. SXTC
2.93 USD -0.05 (-1.68%)
At closeNov 5, 2026, 5:56 PM EST
2.83 -0.10 -3.41%
After hours · Nov 5, 5:56 PM ET
2.76 Day range 3.02
2.71 52-week range 8,376,000.00
- YTD
- -100.00%
- 1 year
- -100.00%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 41 | 4.30K | 27.76K | 33.62K | 339.13K | |
| 889.39K | 1.38M | 1.40M | 1.58M | 1.69M | |
| -6.48M | -1.67M | -1.67M | -4.45M | -4.75M | |
| -6.21M | -3.30M | -3.10M | -5.93M | -5.74M | |
| -73,040.00 | -2,785,360.00 | -34,285,280.00 | -213,404,293.00 | -1,324,012,138.00 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 28.18M | 18.13M | 12.08M | 17.37M | 15.57M | |
| 34.75M | 21.66M | 23.13M | 29.55M | 33.55M | |
| 5.05M | 6.22M | 9.20M | 14.86M | 17.12M | |
| 1.12M | 983.88K | 2.65M | 3.76M | 2.05M | |
| 29.71M | 15.44M | 13.93M | 14.69M | 16.42M |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -4.02M | -2.35M | -1.93M | -80.76K | 268.29K | |
| -1.25M | 63.52K | 26.42K | -12.30K | -46.91K | |
| 14.43M | 8.40M | -2.62M | 2.94M | 1.60M | |
| 10.05M | 6.05M | -5.29M | 1.80M | 2.21M |